TrialAsia-Pacific journal of clinical oncology2022

Efficacy, toxicity, and quality-of-life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single-arm phase 2 trial from Asia.

Janice S H Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.